Abbott Nutrition said it could restart baby formula production at its Michigan factory within two weeks
Abby Wallace May 12, 2022, 8:44 AM
Abbott Nutrition said it could restart production at its Michigan factory “within two weeks.”
The factory has been closed since several formulas produced there were subject to recalls.
The recalls were related to complaints of bacterial infections in four infants.
Abbott Nutrition said it could restart production of baby formula at its shuttered Michigan plant within two weeks, ending a suspension triggered by complaints of illnesses in children that has contributed to severe shortages of the product.
In a statement posted to its website on Wednesday, Abbott said that it could resume production at its Sturgis, MI factory “within two weeks,” pending FDA approval. Abbott said: “After a thorough review of all available data, there is no evidence to link our formulas to these infant illnesses.”
Abbott announced in February that is was recalling several lots of the formula brands Similac, Alimentum, and EleCare in February, after four complaints linked to cronobacter sakazakii – an environmental bacteria – in infants who had consumed formula manufactured at the site. According to the FDA, which has been investigating whether the illnesses were linked to the Michigan plant, the sick infants all consumed powdered formula produced there.
The company added Wednesday that all finished products tested by Abbott and the US Food and Drug Administration during an inspection had tested negative for the bacterial strains.
The FDA did not immediately respond to Insider’s request for comment.